Advances in Sepsis (Vol. 6, No. 2)

Faculty

Needs Statement

Advances in Sepsis, a CME-accredited educational program, systematically identifies, evaluates, and places into clinical context the most important recent studies into the science and medicine of severe sepsis and septic shock. It provides rapid access for busy specialists to a critical and clinically relevant review of the developments that will have most impact on their day-to-day practice and is designed to provide management options for clinicians to allow them to better diagnose and treat patients with sepsis.

Each issue of Advances in Sepsis will present carefully constructed review articles, written by practicing specialists in intensive care medicine, anesthesiology, pulmonology, infectious diseases, and related disciplines and developed to equip readers with practical knowledge of the area under discussion. These articles are commissioned to support particular educational themes identified by the Editors-in- Chief, Editorial Advisory Board, and readers. This issue of Advances in Sepsis presents three such leading articles.

Target Audience

This activity is designed to meet the educational needs of multidisciplinary clinicians and healthcare professionals involved in the care of patients with severe sepsis and septic shock.

Objectives

1. Discuss the techniques for measurement and calculation of cardiac output and tissue;
2. Identify the role of fluid loading and vasopressors in maintenance of cardiac output and tissue perfusion;
3. Recognize the titration of fluids and vasopressors in septic shock patients;
4. Discuss the structure and function of immunoglobulins;
5. Identify the rationale for the therapeutic administration of IvIg in sepsis;
6. Review the reported clinical uses of IvIg;
7. Discuss the hypothesized therapeutic modes of action of HV-HF in sepsis;
8. Discuss the distinct hemofiltration methods and strategies;
9. Discuss the In vivo and human studies in which HV-HF has been employed.

Accreditation

Medicine
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of the University of Kentucky College of Medicine and Remedica Medical Education. The University of Kentucky College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

The University of Kentucky College of Medicine designates this educational activity for a maximum of 2.00 AMA PRA Category 1 Credits™. Each physician should claim only those hours of credit actually spent in the educational activity.

The University of Kentucky College of Medicine presents this activity for educational purposes only. Participants are expected to utilize their own expertise and judgment while engaged in the practice of medicine. The content of the presentations is provided solely by presenters who have been selected for presentations because of recognized expertise in their field.

Faculty Disclosure

None of the authors report any relevant financial relationships with commercial interests of healthcare products or services related to this activity.

Disclosures from all contributing editors can be found in the content.  

Activity Sponsorship

This activity is jointly sponsored by the University of Kentucky and Remedica Medical Education. Supported by an unrestricted educational grant from Eli Lilly and Company.